Cargando…
Liquid Biopsy for Solid Ophthalmic Malignancies: An Updated Review and Perspectives
SIMPLE SUMMARY: To date, there is no treatment for metastatic uveal melanoma. Identifying its metastatic spread is essential. Liquid biopsy can identify patients at risk of metastatic spread early. Here, we aim to summarize the current knowledge of liquid biopsy in ophthalmic malignant tumors, inclu...
Autores principales: | Martel, Arnaud, Baillif, Stephanie, Nahon-esteve, Sacha, Gastaud, Lauris, Bertolotto, Corine, Roméo, Barnabé, Mograbi, Baharia, Lassalle, Sandra, Hofman, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694640/ https://www.ncbi.nlm.nih.gov/pubmed/33172021 http://dx.doi.org/10.3390/cancers12113284 |
Ejemplares similares
-
Assessment of Different Circulating Tumor Cell Platforms for Uveal Melanoma: Potential Impact for Future Routine Clinical Practice
por: Martel, Arnaud, et al.
Publicado: (2023) -
Need for a Dedicated Ophthalmic Malignancy Clinico-Biological Biobank: The Nice Ocular MAlignancy (NOMA) Biobank
por: Martel, Arnaud, et al.
Publicado: (2023) -
New Targeted Therapies and Immunotherapies for Locally Advanced Periocular Malignant Tumours: Towards a New ‘Eye-Sparing’ Paradigm?
por: Martel, Arnaud, et al.
Publicado: (2021) -
Small but Challenging Conjunctival Melanoma: New Insights, Paradigms and Future Perspectives
por: Nahon-Estève, Sacha, et al.
Publicado: (2021) -
Recent advances in understanding the role of HES6 in cancers
por: Krossa, Imène, et al.
Publicado: (2022)